Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 5,000,033 shares of Shattuck Labs, Inc. common stock as of September 30, 2026.
Key Highlights
- Three reporting persons: Deep Track Capital, LP (Delaware), Deep Track Biotechnology Master Fund, Ltd. (Cayman Islands), and David Kroin (United States) each reported the same aggregate beneficial ownership.
- Aggregate beneficial ownership: Each reporting person disclosed 5,000,033 shares beneficially owned, representing 4.92% of the class.
- No sole voting or dispositive power: All 5,000,033 shares are held with shared voting power and shared dispositive power; sole voting and sole dispositive power are each reported as 0.
- Pre-Funded Warrants included: The 5,000,033 shares include 1,293,299 Pre-Funded Warrants exercisable into common stock, subject to a 9.99% maximum percentage exercise limitation.
- Share count basis: The percent of class was calculated using 101,656,552 shares, derived from 100,363,253 shares of common stock outstanding as of August 7, 2026, plus 1,293,299 Pre-Funded Warrants.
- Control person relationship: According to the filing, Deep Track Capital, LP is the relevant entity for which David Kroin may be considered a control person.
Deep Track Capital's Amended Ownership Position in Shattuck Labs
The three reporting persons filed this Schedule 13G as Amendment No. 1, with a triggering event date of September 30, 2026. The filing covers common stock of Shattuck Labs, Inc. (NASDAQ:STTK), par value $0.0001 per share, with CUSIP number 82024L103. Shattuck Labs is headquartered at 500 W. 5th Street, Suite 1200, Austin, TX 78701, according to the filing.
According to the filing, the aggregate beneficial ownership of 5,000,033 shares was calculated using a total share base of 101,656,552 shares. That figure combines 100,363,253 shares of common stock outstanding as of August 7, 2026, as reported in the issuer's 10-Q filed with the SEC on August 11, 2026, plus 1,293,299 Pre-Funded Warrants that the reporting persons indicated would be converted to common stock up to the maximum percentage. The filing notes that the issuer "shall not effect the exercise of any portion of the Pre-Funded Warrants, to the extent that after giving effect to such exercise, the holder collectively would beneficially own in excess of 9.99% ... of the number of Common Stock outstanding immediately after giving effect to such exercise."
The filing also states, under Item 5, that ownership represents 5 percent or less of the class, consistent with the 4.92% figure reported. Item 6 notes that ownership of more than 5 percent on behalf of another person is "Not Applicable." The certifications included in the filing state that the securities "were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."
What Was Disclosed
Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin jointly filed an amended Schedule 13G disclosing aggregate beneficial ownership of 5,000,033 shares, or 4.92%, of Shattuck Labs, Inc. common stock as of September 30, 2026, including 1,293,299 Pre-Funded Warrants.





Please wait processing your request...